Skip to main content
. 2021 Dec 5;16:173. doi: 10.1186/s11671-021-03628-6

Table 1.

List of nanomedicines for cancer therapy approved by FDA [156159]

Tradename Material Drug Company Indication Year(s) approved
Doxil® Liposome-PEG Doxorubicin Janssen MBC, metastatic ovarian cancer 1995
Eligard® PLGA Leuprolide acetate Tolmar Prostate Cancer 2002
Abraxane® Albumin Paclitaxel Celgene Metastatic breast cancer 2005
Genexol PM® mPEG-PLA Paclitaxel Samyang Corporation Metastatic breast cancer 2007
Onivyde® Liposome Irinotecan Merrimack Pancreatic cancer 2015